We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Audiological Disturbances in Vitiligo

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2007 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
ClinicalTrials.gov Identifier:
First Posted: June 8, 2007
Last Update Posted: July 25, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hadassah Medical Organization
The purpose of this study is to determine wether vitiligo patients have more audiological abmnormalities, than the healthy population.

Vitiligo Hearing Loss

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   3 Years to 50 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • vitligo patients under 50. healthy patients under 50 for control group

Exclusion Criteria:

  • above age 50. systemic disease. exposure to loud noise in past. familial history of deafness use of autotoxuc drugs or steroids. autoimmune/metabolic/neurologic/vascular disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00484224

Contact: Arieh Ingber, Prof. 972 2 6776366 Arieh@hadassah.org.il

Hadassah Medical Organization Not yet recruiting
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: Arieh Ingber, Prof. Hadassah Medical Organization
  More Information

ClinicalTrials.gov Identifier: NCT00484224     History of Changes
Other Study ID Numbers: qwer1234-HMO-CTIL
First Submitted: June 7, 2007
First Posted: June 8, 2007
Last Update Posted: July 25, 2007
Last Verified: May 2007

Additional relevant MeSH terms:
Hearing Loss
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Pigmentation Disorders
Skin Diseases